Poster Title: Lysosomal-associated membrane protein-1-targeting of Epstein–Barr virus nuclear antigen 1 (EBNA1) elicits potent immune responses and inhibits tumor growth in preclinical studies by Dr. Pratima Sinha, Ph.D. Presentation Date: ...
Poster Title: Lysosomal-associated membrane protein-1-targeting of a poly-neoepitope DNA vaccine elicits potent immune responses and inhibits tumor growth by Dr. Pratima Sinha, Ph.D. Presentation Date: Saturday, November 9th 7:00 am ...
Poster Title: Functional evaluation of isoforms present in pDNA vaccines Poster Session Date: Tuesday, November 6, 2018 Location: Aldevron, Fargo ND Download poster here.
Poster Title: Lysosomal-associated membrane protein-1-targeting of the large T antigen of Merkel cell polyomavirus elicits potent CD4+ T cell responses Poster Session Date and Time: Monday, October 21, 2019 11:15 ...
Poster Title: DNA vaccine co-expressing Her2/ErbB2 antigen, fused with LAMP, elicits strong antitumor effects in vivo by increasing tumor infiltration with CD8+ T cells Session Category: Immunology Session Title: Late-Breaking ...
Immunomic Therapeutics, Inc. today presented late-breaking preclinical data which shows that its investigational nucleic acid platform, UNITE, may enhance antitumor immunity when used in connection with its investigational DNA vaccine, ...
Astellas Announces FDA Fast Track Designation for ASP0892, DNA Vaccine for Mitigation of Severe Hypersensitivity Reactions Due to Peanut Allergy TOKYO, Dec. 20, 2016 /PRNewswire/ -- Astellas Pharma Inc. ...
By Colin Magowan A new interest has emerged on the CD4+ helper T cell and its role in anti-tumor responses. This renewed focus on the importance of this cell population ...